• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HOXB13突变及在前列腺发育和癌症中的结合伴侣:功能、临床意义及未来方向

HOXB13 mutations and binding partners in prostate development and cancer: Function, clinical significance, and future directions.

作者信息

Brechka Hannah, Bhanvadia Raj R, VanOpstall Calvin, Vander Griend Donald J

机构信息

The Committee on Cancer Biology, The University of Chicago, Chicago, IL, USA.

The Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA.

出版信息

Genes Dis. 2017 Jun;4(2):75-87. doi: 10.1016/j.gendis.2017.01.003. Epub 2017 Feb 16.

DOI:10.1016/j.gendis.2017.01.003
PMID:28798948
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5548135/
Abstract

The recent and exciting discovery of germline mutations in familial prostate cancer has brought HOX signaling to the forefront of prostate cancer research. An enhanced understanding of HOX signaling, and the co-factors regulating HOX protein specificity and transcriptional regulation, has the high potential to elucidate novel approaches to prevent, diagnose, stage, and treat prostate cancer. Toward our understanding of HOX biology in prostate development and prostate cancer, basic research in developmental model systems as well as other tumor sites provides a mechanistic framework to inform future studies in prostate biology. Here we describe our current understanding of HOX signaling in genitourinary development and cancer, current clinical data of mutations in multiple cancers including prostate cancer, and the role of HOX protein co-factors in development and cancer. These data highlight numerous gaps in our understanding of HOX function in the prostate, and present numerous potentially impactful mechanistic and clinical opportunities for future investigation.

摘要

家族性前列腺癌中生殖系突变这一近期令人兴奋的发现,已将HOX信号传导推到前列腺癌研究的前沿。对HOX信号传导以及调节HOX蛋白特异性和转录调控的辅助因子的深入理解,极有可能阐明预防、诊断、分期和治疗前列腺癌的新方法。为了理解HOX生物学在前列腺发育和前列腺癌中的作用,发育模型系统以及其他肿瘤部位的基础研究提供了一个机制框架,为未来前列腺生物学研究提供参考。在此,我们描述了目前对HOX信号传导在泌尿生殖系统发育和癌症中的理解、包括前列腺癌在内的多种癌症中突变的当前临床数据,以及HOX蛋白辅助因子在发育和癌症中的作用。这些数据凸显了我们对前列腺中HOX功能理解上的诸多空白,并为未来研究提供了众多潜在的、有影响力的机制和临床研究机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d42/6136592/f8c15c0df0bd/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d42/6136592/d0fad0086fc0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d42/6136592/f8c15c0df0bd/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d42/6136592/d0fad0086fc0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d42/6136592/f8c15c0df0bd/gr2.jpg

相似文献

1
HOXB13 mutations and binding partners in prostate development and cancer: Function, clinical significance, and future directions.HOXB13突变及在前列腺发育和癌症中的结合伴侣:功能、临床意义及未来方向
Genes Dis. 2017 Jun;4(2):75-87. doi: 10.1016/j.gendis.2017.01.003. Epub 2017 Feb 16.
2
HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancer.HOXB13 与 MEIS1 的相互作用改变了前列腺癌的增殖和基因表达。
Prostate. 2019 Mar;79(4):414-424. doi: 10.1002/pros.23747. Epub 2018 Dec 17.
3
MEIS-mediated suppression of human prostate cancer growth and metastasis through HOXB13-dependent regulation of proteoglycans.MEIS 通过 HOXB13 依赖性调控蛋白聚糖抑制人前列腺癌生长和转移。
Elife. 2020 Jun 18;9:e53600. doi: 10.7554/eLife.53600.
4
MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease.MEIS1 和 MEIS2 的表达与前列腺癌进展:HOXB13 结合伴侣在转移疾病中的作用。
Clin Cancer Res. 2018 Aug 1;24(15):3668-3680. doi: 10.1158/1078-0432.CCR-17-3673. Epub 2018 May 1.
5
HOXB13 is co-localized with androgen receptor to suppress androgen-stimulated prostate-specific antigen expression.HOXB13与雄激素受体共定位,以抑制雄激素刺激的前列腺特异性抗原表达。
Anat Cell Biol. 2010 Dec;43(4):284-93. doi: 10.5115/acb.2010.43.4.284. Epub 2010 Dec 31.
6
Oncogenic mechanisms of missense mutations in prostate carcinogenesis.前列腺癌发生中错义突变的致癌机制。
Oncoscience. 2016 Oct 31;3(9-10):288-296. doi: 10.18632/oncoscience.322. eCollection 2016.
7
Somatic molecular subtyping of prostate tumors from HOXB13 G84E carriers.HOXB13 G84E携带者前列腺肿瘤的体细胞分子亚型分析。
Oncotarget. 2017 Apr 4;8(14):22772-22782. doi: 10.18632/oncotarget.15196.
8
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.胚系 HOXB13 突变 p.G84E 和 p.R217C 不会增加乳腺癌风险。
Sci Rep. 2020 Jun 16;10(1):9688. doi: 10.1038/s41598-020-65665-y.
9
The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies.HOXB13基因G84E突变与前列腺癌及其他恶性肿瘤风险增加相关。
Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1366-72. doi: 10.1158/1055-9965.EPI-15-0247. Epub 2015 Jun 24.
10
Evaluation of homeobox protein B13 (HOXB13) gene G84E mutation in patients with prostate cancer.评估前列腺癌患者中同源盒蛋白 B13(HOXB13)基因 G84E 突变。
World J Urol. 2024 Aug 8;42(1):476. doi: 10.1007/s00345-024-05186-9.

引用本文的文献

1
LncRNA-536 and RNA-Binding Protein RBM25 Interactions in Pulmonary Artery Smooth Muscle Cells: Implications in Pulmonary Hypertension.肺动脉平滑肌细胞中lncRNA - 536与RNA结合蛋白RBM25的相互作用:对肺动脉高压的影响
Arterioscler Thromb Vasc Biol. 2025 Jun 26. doi: 10.1161/ATVBAHA.125.322734.
2
Integrating molecular diagnostics for early prostate cancer detection.整合分子诊断技术用于早期前列腺癌检测。
Oncoscience. 2025 May 26;12:58-64. doi: 10.18632/oncoscience.620. eCollection 2025.
3
ERBB2/HOXB13 co-amplification with interstitial loss of BRCA1 defines a unique subset of breast cancers.

本文引用的文献

1
PBX3 is a putative biomarker of aggressive prostate cancer.PBX3是侵袭性前列腺癌的一种潜在生物标志物。
Int J Cancer. 2016 Oct 15;139(8):1810-20. doi: 10.1002/ijc.30220. Epub 2016 Jun 25.
2
Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer.转移性前列腺癌男性患者肿瘤之间存在显著的个体间基因组多样性,而个体内基因组多样性有限。
Nat Med. 2016 Apr;22(4):369-78. doi: 10.1038/nm.4053. Epub 2016 Feb 29.
3
Prevalence of the HOXB13 G84E mutation in Danish men undergoing radical prostatectomy and its correlations with prostate cancer risk and aggressiveness.
ERBB2/HOXB13共扩增伴BRCA1间质缺失定义了一种独特的乳腺癌亚型。
Breast Cancer Res. 2024 Dec 18;26(1):185. doi: 10.1186/s13058-024-01943-1.
4
Snake venom toxins as potential therapeutic agents in the treatment of prostate cancer.蛇毒毒素作为治疗前列腺癌的潜在治疗剂。
Mol Biol Rep. 2024 Nov 14;51(1):1153. doi: 10.1007/s11033-024-09970-z.
5
LncRNA-536 and RNA Binding Protein RBM25 Interactions in Pulmonary Arterial Hypertension.长链非编码RNA-536与RNA结合蛋白RBM25在肺动脉高压中的相互作用
bioRxiv. 2024 Aug 28:2024.08.27.610011. doi: 10.1101/2024.08.27.610011.
6
Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells.单细胞分析整合定义了去势抵抗性前列腺腔细胞的表观遗传学基础。
Cell Stem Cell. 2024 Aug 1;31(8):1203-1221.e7. doi: 10.1016/j.stem.2024.05.008. Epub 2024 Jun 14.
7
HOXA9 versus HOXB9; particular focus on their controversial role in tumor pathogenesis.HOXA9 与 HOXB9;特别关注它们在肿瘤发病机制中的争议性作用。
J Appl Genet. 2024 Sep;65(3):473-492. doi: 10.1007/s13353-024-00868-x. Epub 2024 May 16.
8
Decoding the Influence of Obesity on Prostate Cancer and Its Transgenerational Impact.解析肥胖对前列腺癌的影响及其跨代效应。
Nutrients. 2023 Nov 21;15(23):4858. doi: 10.3390/nu15234858.
9
Characterization of HOXB13 expression patterns in localized and metastatic castration-resistant prostate cancer.HOXB13 在局限性和转移性去势抵抗性前列腺癌中的表达模式特征。
J Pathol. 2024 Jan;262(1):105-120. doi: 10.1002/path.6216. Epub 2023 Oct 18.
10
Immunoreactivity of HOXB13 in Neuroendocrine Neoplasms Is a Sensitive and Specific Marker of Rectal Well-Differentiated Neuroendocrine Tumors.HOXB13 在神经内分泌肿瘤中的免疫反应性是直肠高分化神经内分泌肿瘤的一个敏感且特异的标志物。
Endocr Pathol. 2023 Sep;34(3):333-341. doi: 10.1007/s12022-023-09779-9. Epub 2023 Aug 8.
丹麦接受根治性前列腺切除术男性中HOXB13 G84E突变的患病率及其与前列腺癌风险和侵袭性的相关性。
BJU Int. 2016 Oct;118(4):646-53. doi: 10.1111/bju.13416. Epub 2016 Feb 12.
4
Cancer statistics, 2016.癌症统计数据,2016 年。
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
5
The Molecular Taxonomy of Primary Prostate Cancer.原发性前列腺癌的分子分类学
Cell. 2015 Nov 5;163(4):1011-25. doi: 10.1016/j.cell.2015.10.025.
6
Identification of Two Novel HOXB13 Germline Mutations in Portuguese Prostate Cancer Patients.葡萄牙前列腺癌患者中两个新型HOXB13种系突变的鉴定
PLoS One. 2015 Jul 15;10(7):e0132728. doi: 10.1371/journal.pone.0132728. eCollection 2015.
7
The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies.HOXB13基因G84E突变与前列腺癌及其他恶性肿瘤风险增加相关。
Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1366-72. doi: 10.1158/1055-9965.EPI-15-0247. Epub 2015 Jun 24.
8
Pbx3 and Meis1 cooperate through multiple mechanisms to support Hox-induced murine leukemia.Pbx3和Meis1通过多种机制协同作用,以支持Hox诱导的小鼠白血病。
Haematologica. 2015 Jul;100(7):905-13. doi: 10.3324/haematol.2015.124032. Epub 2015 Apr 24.
9
Cellular and molecular insights into Hox protein action.Hox 蛋白作用的细胞和分子见解。
Development. 2015 Apr 1;142(7):1212-27. doi: 10.1242/dev.109785.
10
Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes.英国男性中 HOXB13 G84E 种系突变的流行率及其与前列腺癌风险、肿瘤特征和临床结局的相关性。
Ann Oncol. 2015 Apr;26(4):756-761. doi: 10.1093/annonc/mdv004. Epub 2015 Jan 16.